Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

ver descrição completa

Detalhes bibliográficos
Autor principal: Clemens, Sue Ann Costa (author)
Outros Autores: Folegatti, Pedro M. (author), Emary, Katherine R. W. (author), Weckx, Lily Yin (author), Ratcliff, Jeremy (author), Bibi, Sagida (author), Sprinz, Eduardo (author), Pollard, Andrew J. (author), Oxford COVID Vaccine Trial Group (author)
Formato: other article
Idioma:eng
Publicado em: 2022
Assuntos:
Doenças transmissíveis
SARS-CoV-2
COVID-19
Vacinas contra COVID-19
Carga viral
Infectious diseases
Vaccines
Viral infection
Texto completo:http://hdl.handle.net/10183/236682
País:Brasil
Oai:oai:www.lume.ufrgs.br:10183/236682

Texto Completo

http://hdl.handle.net/10183/236682

Registos relacionados